News
20 articles
-
Fisetin Senolytics in 2026: Clinical Trial Updates, Japanese Strawberry Research, and What the Evidence Says Now
What the 2025-2026 Phase 1-2 clinical trial data windows for fisetin senolytics show, how Japan's ichigo agriculture fits, and what changed for supplement buyers this year.
-
NMN Supplement Market 2026: Japan-Manufactured vs US Brands on Amazon — Dose, Price, and Regulatory Status
Japan-manufactured NMN vs US brands: 2026 Amazon bestseller analysis by dose tier, quality certification, price, and FDA regulatory status.
-
Japan's 2026 Aging Society White Paper: Longevity Statistics, Mortality Trends, and What the Projections Show
What Japan's 2026 高齢社会白書 reveals about cause-of-death structure, the male-female longevity gap, population projections to 2040, and how to read the demographic data critically.
-
Japan Longevity Science Q3 2026: Research Developments in Gut Biology, NAD+ Pathways, and Epigenetic Age
Q3 2026 digest: what Japanese centenarian microbiome research, NAD+ trials, senescence studies, and epigenetic clock data are showing mid-year.
-
Why Japan's Adult Obesity Rate Sits Below 5%: Diet Patterns, Food Policy, and What the Data Shows
Japan's obesity prevalence by international BMI standards is roughly a tenth of US levels. A look at the dietary patterns, food environment, and cohort data behind the gap — and the demographic shifts that complicate the picture.
-
Japan's Centenarian Population Approaches 100,000: The 2026 Record and Policy Response
Japan's centenarian count hit 95,000-plus in 2025 and approaches 100,000. What the 2026 MHLW milestone would mean and how longevity policy is responding.
-
Japan's Supercentenarians in 2026: World Rankings, Age Validation, and the Longevity Science Behind Living Past 110
Japan leads validated supercentenarian rankings worldwide. What 2026 data shows, how extreme ages are verified, and what research links to living past 110.
-
Japan's Silver Economy in 2026: Wellness Market Size, Consumer Spending, and Why Global Investors Are Watching
Japan at 29% elderly population has built the world's most structured silver wellness market. A look at sizing, policy drivers, and overseas investor interest.
-
Japan Aging Society White Paper 2026: Centenarian Data, Healthy Life Expectancy, and Policy Progress
Japan's 2026 Aging Society White Paper covers centenarian population data, healthy life expectancy, prefecture longevity rankings, and Health Japan 21 progress.
-
Japan's Functional Food Labeling Standards After the Kobayashi Recall: What the 2025–2026 Reform Changes
How Japan's Consumer Affairs Agency revised FFC notification requirements after the 2024 Kobayashi recall — and where the reformed framework stands relative to EU Qualified Health Claims and FDA structure/function rules.
-
Japan's NMN and NAD+ Supplement Regulations in 2026: What Overseas Buyers Need to Know
NMN's regulatory status in Japan, the US, and the EU compared — plus 2026 updates for ashitaba chalcone, resveratrol, and Japan's functional food notification system.
-
Japan Longevity Research Q3 2026: Four Developments in the Research Calendar
A calibrated midyear digest of Japan's Q3 2026 longevity research pipeline: the September centenarian count, Okinawa Blue Zones updates, Health Japan 21 indicators, and the FFC regulatory pipeline.
-
Japan's Functional Food Regulations in 2026: FOSHU, FFC, and Why the Label Language Matters
Japan's two-tier functional food system — FOSHU and FFC — explained for overseas readers, with 2026 claim status for lactobacillus, lutein, EPA/DHA, and plasmalogen.
-
Japan's 2025 Centenarian Record: 95,000+ People Aged 100 and Why the Number Keeps Rising
Japan's centenarian count topped 95,000 in 2025, the 44th consecutive record year. Why the number keeps rising: healthcare, diet, and community structure.
-
Okinawa's Centenarian Decline: What Changed Between 1985 and Now
Okinawa ranked first globally for centenarian density in the 1980s. By 2020, Okinawan men ranked 36th of 47 prefectures. The evidence behind what changed.
-
Health Japan 21, Third Phase: What Japan's 2024–2032 National Health Targets Actually Say
Health Japan 21 third phase (2024–2032): MHLW targets for healthy life expectancy, lifestyle disease risk, and social environment, with 2026 progress context.
-
Japan in OECD Healthy Aging Data: A 2026 Reading of the Rankings and What Drives Them
How Japan performs across OECD healthy aging metrics in 2026, what has shifted from prior reporting cycles, regional longevity cross-reference, and a factor breakdown across policy, diet, and social bonds.
-
Japanese Centenarian Daily Habits: What NHK's 2026 Documentary Coverage Actually Shows
What NHK's 2026 centenarian documentary documented across diet, movement, sleep, and social bonds — and how the footage maps to cohort evidence.
-
Japan Longevity Research 2026: Annual Highlights From MHLW Centenarian Statistics and Active Cohort Programs
MHLW annual centenarian data trajectory, Tsurugaya Project and JACC cohort updates, and how NHK Special 2025-2026 covered Japan's longevity landscape — calibrated review for 2026.
-
Japan's Blue Zones in 2026: What the Updated Research Actually Shows
What Blue Zones researchers and MHLW cohort data from 2025-2026 say about Japan's longevity regions — Okinawa, Kyotango, Nagano — and where the concept's structural limits become visible.